Susan Bullman receives TAMEST Mary Beth Maddox Award for breakthrough tumor microbiome research
Susan Bullman, Ph.D., associate professor of Immunology and Gastrointestinal Medical Oncology at The University of Texas MD Anderson Cancer Center, has received the 2027 Mary Beth Maddox Award and Lectureship from the Texas Academy of Medicine, Engineering, Science and Technology (TAMEST) in recognition of her contributions to understanding how bacteria within tumors influence cancer development, treatment response and immune function...
Allison Institute convenes leading scientists and clinicians for fourth annual scientific symposium on frontiers of immunotherapy
Annual meeting focused on immune set points andthe regulatory mechanisms shaping the next generation of cancer immunotherapies
Symposium featured...
Newly discovered pathway fuels production of cancer-driving proteins
Researchers identified a previously unknown mechanism that helps cancer cells produce cancer-promoting proteins, including KRAS
Blocking a specific...
ESMO 2026: New targeted therapy improved survival for patients with KRAS-mutated lung cancer
Phase 3 trial finds that next-generation KRAS G12C inhibitor divarasib significantly reduced risk of cancer progressing and death
Patients receiving divarasib lived a median of approximately 18 months
Fewer severe treatment-related side effects were reported with divarasib
ABSTRACT: LBA5
Patients with previously treated advanced KRAS G12C-mutant non-small cell lung cancer (NSCLC) lived significantly...
ESMO 2026: UT MD Anderson highlights innovative approaches to monitor, prevent and treat cancer
ABSTRACTS: 3438O, 4244RO, 540RO, 2490P
Researchers at The University of Texas MD Anderson Cancer Center presented new findings at the...
ESMO 2026: Immunotherapy combination extends survival in advanced endometrial cancer
Patients receiving durvalumab plus olaparib lived almost one year longer than patients treated with chemotherapy alone
Study...
UT MD Anderson welcomes eight new members to Board of Visitors
The University of Texas MD Anderson Cancer Center is pleased to announce eight new members to its Board of Visitors (BOV), the institution...
UT MD Anderson names 2026 winners of The Brown Foundation Award for Excellence in Oncology Nursing
The University of Texas MD Anderson Cancer Center yesterday awarded Lakeisha Keller-Davis, RN, MSN, CMSRN, and Ellen C. Mullen, Ph.D., APRN-BC...
UT MD Anderson’s Albert Koong and Katy Rezvani elected to the National Academy of Medicine
Albert Koong, M.D, Ph.D., honored for advances in radiation therapy technologies and new discoveries in cancer biology
Katy Rezvani...
Structurally guided therapy shows promise for patients with specific EGFR-mutated lung cancer in Phase 1b trial
Firmonertinib is an experimental therapy from ArriVent BioPharma for patients with EGFR PACC mutations
PACC mutations make up about...